GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) » Definitions » EPS (Diluted)

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) EPS (Diluted) : TND (TTM As of . 20)


View and export this data going back to 2001. Start your Free Trial

What is Societe des Industries Pharmaceutiques de Tunisie-S I PHA T EPS (Diluted)?

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Earnings per Share (Diluted) for the six months ended in . 20 was TND0.00.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's EPS (Basic) for the six months ended in . 20 was TND0.00.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's EPS without NRI for the six months ended in . 20 was TND0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T EPS (Diluted) Historical Data

The historical data trend for Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T EPS (Diluted) Chart

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Annual Data
Trend
EPS (Diluted)

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Semi-Annual Data
EPS (Diluted)

Competitive Comparison of Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's PE Ratio distribution charts can be found below:

* The bar in red indicates where Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's PE Ratio falls into.



Societe des Industries Pharmaceutiques de Tunisie-S I PHA T EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Diluted EPS for the fiscal year that ended in . 20 is calculated as

Diluted EPS (A: . 20 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-)/0
=

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Diluted EPS for the quarter that ended in . 20 is calculated as



Societe des Industries Pharmaceutiques de Tunisie-S I PHA T  (XTUN:SIPHA) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) Business Description

Traded in Other Exchanges
N/A
Address
Fondouk Choucha, Ben Arous, TUN, 2013
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T is a Tunisia-based company mainly engaged in manufacturing and distributing medicines and drugs. The company also has its own research and development process to develop generic drugs. It offers pharmaceutical, dietary, hygiene, and cosmetic products in dry, liquid and pasty forms.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) Headlines

No Headlines